Congenital Heart Disease Learning Pathway
Continuity of care takes on a new depth of meaning in the Congenital Heart Disease (CHD) Learning Pathway. Beyond the concern of ensuring that patients and their caretakers make a good transition in care from early life into their adult years, this year’s program focuses on defining a continuous thread of care that leads from birth into adulthood, a thread that connects the dots between the different stages of life, and how therapy or surgical decisions made at one stage of life will affect patients 20 or 30 or more years later.
The field of CHD is evolving, and CHD specialists find they must be innovative almost every day. The unique nature of CHD is that there is no patient in whom CAD, valvular disease, heart failure, cardiomyopathy or another condition is not relevant, which is why the CHD pathway has a multidisciplinary nature. Attendees will challenge “gold standards” in CHD care and open controversial topics to expert panel discussions, debates and audience interaction.
New techniques and technologies offer many possibilities for advancing the care of CHD patients and improving their quality of life, but equally important is the need to bring the science of data to congenital heart disease care. Don’t miss session #693, Congenital Heart Disease Registries: Why I Participate and You Should Too!, and learn more about what the data from national and international registries are telling us. And for a little bit of fun and learning, join us for session #6008, Family Feud: Pediatric Cardiology Marries Adult Congenital — But Do We Practice the Same Way?, in the Engage@ACC.18 Studio.
Making the best decisions with and for patients, no matter their stage of life or purpose, requires a broader understanding of the clinical and science aspects of a decision and a lot of thought and communication with other specialists. You’ll hear input from not only CHD experts, but also from other relevant specialties, such as imaging and intervention and take a serious look at the importance of registries and what their data indicate.
- Innovation in Congenital Cardiac Interventions: Featuring the Dan McNamara Keynote (Session #732)
- Controversies in the Care of Pediatric Patients With Cardiomyopathy (Session #652)
- When Imaging Worlds Collide (Session #665)
- Blinded by Science: Bard High vs. Palmaz High (Session #624)
- Exercise in Congenital Heart Disease: Will She Make It? (Session #609)
- Technical Strategies in Staged Single Ventricle Palliation: Joint Symposium of the American Association for Thoracic Surgeons and the American College of Cardiology (Session #763)
- Highlighted Original Research: Congenital Heart Disease and the Year in Review (Session #908)
- Building for the Future: Developing the ACHD Program (Session #680)
- Personalizing Care for Single Ventricle Patients: From Fetus to Adult (Session #748)
- ACC Intensive: General Cardiologist’s Real-world Approach to Adult Congenital Heart Disease (Session #54 and #55)
Plus, arrive a day early and join us for CHD Community Day 2018! On Friday, March 9 from 1:00 p.m. – 5:00 p.m. we’ll be discussing what it takes to work across disciplines and institutional lines to effectively treat congenital heart disease. Be a part of the conversation and RSVP for this special event! Learn more >>>
| 2018 American College of Cardiology Foundation. Visit ACC.org|